Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Houghton, Catherine M ^a,c   Lawson, Naomi ^a   Borrill, Zoe L ^a,c   Wixon, Claire L ^b   Yoxall, Sally ^b   Langley, Stephen J ^a   Woodcock, Ashley ^a,c   Singh, Dave ^a,c  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; DRUG DERIVATIVE; FLUTICASONE; FLUTICASONE SALMETEROL COMBINATION; FLUTICASONE-SALMETEROL COMBINATION; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION;

ADULT; ALBUTEROL; ANDROSTADIENES; ASTHMA; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGY;

EID: 34848901107     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-52     Document Type: Article

References (28)

1. Houghton CM, Woodcock AA, Singh D. A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol 2004, 58:134-141. 10.1111/j.1365-2125.2004.02105.x, 15255795.
2. Houghton CM, Woodcock AA, Singh D. A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma. Br J Clin Pharmacol 2005, 59:152-159. 10.1111/j.1365-2125.2004.2262.x, 15676036.
3. Tattersfield AE, Keeping IM. Assessing change in airway calibre - measurement of airway resistance. Br J Clin Pharmacol 1979, 8:307-319.
4. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001, 14:341-350. 10.1006/pupt.2001.0310, 11603948.
5. Pride NB. Forced oscillation techniques for measuring mechanical properties of the respiratory system. Thorax 1992, 47:317-320.
6. Hellinckx J, Cauberghs M, de Boeck K, Demedts M. Evaluation of impulse oscillation system: comparison with forced oscillation technique and body plethysmography. Eur Respir J 2001, 18:564-570. 10.1183/09031936.01.00046401, 11589356.
7. van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999, 54:207-212.
8. Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH. Addition of salmeterol to fluticasone propionate treatment in moderate to severe asthma. Respir Med 2003, 97:555-562. 10.1053/rmed.2003.1483, 12735675.
9. Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations. J Allergy Clin Immunol 2001, 107(Suppl 5):783-789.
10. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. NHLBI Workshop Report 2002, National Institutes for Health National Heart, Lung and Blood Institute, NIH Publication Number 02-3659., Global Initiative for Asthma (GINA).
11. Pellegrino R, Sterk PJ, Sont JK, Brusasco V. Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. Eur Respir J 1998, 12:1219-1227. 10.1183/0903.1936.98.12051219, 9864024.
12. Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness. Chest 2002, 122:806-811. 10.1378/chest.122.3.806, 12226017.
13. van Noord JA, Smeets JJ, Raaijimaker JAM, Bommer AM, Maesen FP. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996, 9:1684-1688. 10.1183/09031936.96.09081684, 8866595.
14. Palmqvist M, Perrson G, Lazer L, Rosenborg J, Larsson P, Lotvall J. In haled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Respir J 1997, 10:2484-2489. 10.1183/09031936.97.10112489, 9426083.
15. Van Noord JA, Smeets J, Clement J, van de Woestijne KP, Demedts M. Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med 1994, 150:551-554.
16. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002, 109(Suppl 2):S447-S460.
17. Currie GP, Stenback S, Lipworth BJ. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. Br J Clin Pharmacol 2003, 56:11-17. 10.1046/j.1365-2125.2003.01831.x, 12848770.
18. Mead J. Contribution of compliance of airways to frequency-dependent behaviour of lungs. J Appl Physiol 1969, 26:670-3.
19. De La Hoz RE, Berger KI, Klugh TT, Friedman-Jimenez G, Goldring RM. Frequency depndance of compliance in the evaluation of patients with unexplained respiratory symptoms. Respir Med 2000, 94:221-7. 10.1053/rmed.1999.0719, 10783932.
20. van Noord JA, Clement J, van de Woestijne KP, Demedts M. Total respiratory resistance and reactance in patients with asthma, chronic bronchitis, and emphysema. Am RevRespir Dis 1991, 143(5 Pt 1):922-927.
21. Bouaziz N, Beyaert C, Gauthier R, Monin P, Peslin R, Marchal F. Respiratory system reactance as an indicator of the intrathoracic airway response to methacholine in children. Pediatr pulmonol 1996, 22:7-13. 10.1002/(SICI)1099-0496(199607)22:1<7::AID-PPUL2>3.0.CO;2-P, 8856798.
22. Skloot G, Goldman M, Fishler D, Goldman C, Schechter C, Levin S, Teirstein A. Respiratory assessment and physiological symptoms of ironworkers at the world trade center disaster site. Chest 2004, 125:1248-55. 10.1378/chest.125.4.1248, 15078731.
23. Cheung D, Timmers MC, Zwiderman AH, Bel EH, Dijkman JH, Sterk PJ. Long-term effects of a long-acting beta2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992, 327:1198-1203.
24. Britton MG, Earnshaw JS, Palmer JBD. A twelve month comparison of salmeterol and salbutamol in asthmatic patients. Eur Respir J 1992, 5:1062-67.
25. Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol with salbutamol as dry powder formulations in asthmatic patients. Thorax 1993, 48:148-53.
26. Lundback B, Ronmark E, Lindberg A, Jonsson AC, Levsson LG, Petavy F, James M. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med 2006, 100:2-10. 10.1016/j.rmed.2005.09.006, 16243498.
27. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tatteresfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001, 164:1392-1397.
28. Zeiger RS, Bird SR, Kaplan MS, Pearlman DS, Schatz M, Bird S, Hustad C, Edelman J. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med 2005, 118:649-647. 10.1016/j.amjmed.2005.03.003, 15922697.